24 January 2020
How Insys Therapeutics Bribed Doctors and Made Millions | FRONTLINE
Opioid maker Insys Therapeutics bribed doctors to prescribe a drug that’s stronger than heroin. It’s been linked to hundreds of deaths. Speaking publicly for the first time since the criminal trial against Insys executives began, the company’s former VP of sales explains how he ran the scheme. Sales reps with “almost no conscience.” Vulnerable doctors. Quid pro quos.
In his own words, WATCH what Alec Burlakoff says about how Insys bribed doctors to prescribe the opioid painkiller Subsys — and read more about the prison sentencing of Burlakoff and other Insys executives. #OpioidCrisis #InsysTherapeutics #Documentary A full documentary and podcast investigating Insys Therapeutics, from FRONTLINE and The Financial Times, comes to PBS in the spring of 2020. Director: Thomas Jennings Producers: Annie Wong, Nick Verbitsky Associate Producer: Rebecca Blandon Line Producer: Julie Rasquin Camera: John Baynard Audio: John O'Connor Editors: Miles Alvord and Pascal Akesson Music: Griffin Jennings Director of Digital Video: Carla BorrĂ¡s Managing Editor: Andrew Metz Executive Producer: Raney Aronson-Rath Subscribe on YouTube: http://bit.ly/1BycsJW Instagram: https://www.instagram.com/frontlinepbs Twitter: https://twitter.com/frontlinepbs Facebook: https://www.facebook.com/frontline FRONTLINE is streaming more than 200 documentaries online, for free, here: http://to.pbs.org/hxRvQP Funding for FRONTLINE is provided through the support of PBS viewers and by the Corporation for Public Broadcasting. Major funding for FRONTLINE is provided by the John D. and Catherine T. MacArthur Foundation and the Ford Foundation. Additional funding is provided by the Abrams Foundation, the Park Foundation, The John and Helen Glessner Family Trust, the Heising-Simons Foundation, and the FRONTLINE Journalism Fund with major support from Jon and Jo Ann Hagler on behalf of the Jon L. Hagler Foundation.
Subscribe to:
Post Comments (Atom)
-
PLEASE NOTE: BleepingComputer has contacted Maxar Technologies to ask about the possibility of confidential technology data exposure and a ...
-
The Exploration Company, the European rival of SpaceX, has achieved another milestone in funding to develop its space cargo capsule, Nyx. Go...
No comments:
Post a Comment